BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14729077)

  • 1. Thiolated chitosans.
    Bernkop-Schnürch A; Hornof M; Guggi D
    Eur J Pharm Biopharm; 2004 Jan; 57(1):9-17. PubMed ID: 14729077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiolated chitosans: useful excipients for oral drug delivery.
    Werle M; Bernkop-Schnürch A
    J Pharm Pharmacol; 2008 Mar; 60(3):273-81. PubMed ID: 18284806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties.
    Dünnhaupt S; Barthelmes J; Rahmat D; Leithner K; Thurner CC; Friedl H; Bernkop-Schnürch A
    Mol Pharm; 2012 May; 9(5):1331-41. PubMed ID: 22489677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-protected thiolated chitosan: synthesis and in vitro characterization.
    Dünnhaupt S; Barthelmes J; Thurner CC; Waldner C; Sakloetsakun D; Bernkop-Schnürch A
    Carbohydr Polym; 2012 Oct; 90(2):765-72. PubMed ID: 22839999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiolated chitosans: influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties.
    Sakloetsakun D; Iqbal J; Millotti G; Vetter A; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2011 Jun; 37(6):648-55. PubMed ID: 21561400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro evaluation of a novel thiolated chitosan.
    Kafedjiiski K; Krauland AH; Hoffer MH; Bernkop-Schnürch A
    Biomaterials; 2005 Mar; 26(7):819-26. PubMed ID: 15350788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiolated polymers--thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates.
    Bernkop-Schnürch A; Hornof M; Zoidl T
    Int J Pharm; 2003 Jul; 260(2):229-37. PubMed ID: 12842342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-graft-6-mercaptonicotinic acid: synthesis, characterization, and biocompatibility.
    Millotti G; Samberger C; Fröhlich E; Bernkop-Schnürch A
    Biomacromolecules; 2009 Nov; 10(11):3023-7. PubMed ID: 19821557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation.
    Roldo M; Hornof M; Caliceti P; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2004 Jan; 57(1):115-21. PubMed ID: 14729087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive in vitro and in vivo evaluation of thiolated matrix tablets as a gastroretentive delivery system.
    Senyigit ZA; Vetter A; Guneri T; Bernkop-Schnürch A
    Drug Deliv; 2011 Aug; 18(6):405-14. PubMed ID: 21463156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiomers--from bench to market.
    Bonengel S; Bernkop-Schnürch A
    J Control Release; 2014 Dec; 195():120-9. PubMed ID: 24993428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
    Hombach J; Hoyer H; Bernkop-Schnürch A
    Eur J Pharm Sci; 2008 Jan; 33(1):1-8. PubMed ID: 17980561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs.
    Dünnhaupt S; Barthelmes J; Köllner S; Sakloetsakun D; Shahnaz G; Düregger A; Bernkop-Schnürch A
    Carbohydr Polym; 2015 Mar; 117():577-584. PubMed ID: 25498673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiomers: potential excipients for non-invasive peptide delivery systems.
    Bernkop-Schnürch A; Krauland AH; Leitner VM; Palmberger T
    Eur J Pharm Biopharm; 2004 Sep; 58(2):253-63. PubMed ID: 15296953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
    Krauland AH; Guggi D; Bernkop-Schnürch A
    J Control Release; 2004 Mar; 95(3):547-55. PubMed ID: 15023465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational studies of mucin 2 and its interactions with thiolated chitosans: a new insight for mucus adhesion and drug retention.
    Cavalcanti da Silveira CO; Gonçalves ADS; Costa Franca TC; Silva Filho EA
    J Biomol Struct Dyn; 2020 Mar; 38(5):1479-1487. PubMed ID: 31014188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of functional characteristics of preactivated thiolated chitosan as potential therapeutic agent for dry mouth syndrome.
    Laffleur F; Fischer A; Schmutzler M; Hintzen F; Bernkop-Schnürch A
    Acta Biomater; 2015 Jul; 21():123-31. PubMed ID: 25900442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified chitosans for oral drug delivery.
    Werle M; Takeuchi H; Bernkop-Schnürch A
    J Pharm Sci; 2009 May; 98(5):1643-56. PubMed ID: 18781621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
    Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
    Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viscoelastic properties of a new in situ gelling thiolated chitosan conjugate.
    Krauland AH; Hoffer MH; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2005 Oct; 31(9):885-93. PubMed ID: 16306000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.